BDBM50047054 4-[1-(3,4-Dichloro-benzyl)-5-fluoro-1H-benzoimidazol-2-yl]-3,3-dimethyl-butyric acid::CHEMBL18257
SMILES: CC(C)(CC(O)=O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)c(Cl)c1
InChI Key: InChIKey=ZURSNWKXHFEFSL-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prostanoid TP receptor (Homo sapiens (Human)) | BDBM50047054 (4-[1-(3,4-Dichloro-benzyl)-5-fluoro-1H-benzoimidaz...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | 6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Carpibem Curated by ChEMBL | Assay Description Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human platelets | J Med Chem 36: 1175-87 (1993) BindingDB Entry DOI: 10.7270/Q2R49PT8 | |||||||||||
More data for this Ligand-Target Pair |